Posted on 11월 10, 202211/10/22
Maximize In-Licensing Growth
Posted on 9월 14, 20229/14/22
Point of Attack: Developing a Targeted Oncology Account Engagement Strategy and Tactical Platform
Posted on 9월 2, 20229/2/22
Plasma derived medicinal products – What is the way forward?
Posted on 8월 30, 20228/30/22
Successful Early-Stage Out-Licensing Requirements
Posted on 8월 23, 20228/23/22
Social Determinants of Health – What Pharma Can Do!
Posted on 8월 18, 20228/18/22
Flipping the Script to Disrupt, Redefine and Accelerate the Patient Care Journey
Posted on 8월 2, 20228/2/22
How to Ensure Speed and Efficiency When Launching in Canada
Posted on 6월 29, 20226/29/22
An Innovative Approach to Comprehensive Key Opinion Leader (KOL) Mapping
Posted on 6월 1, 20226/1/22
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Posted on 5월 13, 20225/13/22